Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Glyphic Biotechnologies Inc
Profile last edited on: 11/16/23      CAGE: 94M19      UEI: F57WT7JZDH19

Business Identifier: Next generation protein sequencing
Year Founded
2021
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

169 Madison Avenue Suite 2216
New York, NY 10016
   (925) 477-7334
   letschat@glyphic.bio
   www.glyphic.bio
Location: Single
Congr. District: 15
County: San Mateo

Public Profile

Structured around sequencing proteins, Glyphic Biotechnologies- with facilities in Berkekey CA and New York City is a biotechnology startup structured around intentions to revolutionize the field of proteomics. While DNA can reveal biological insights, proteins can actually enable definition of what yj himan body can/will do. The principals of Glyphic Biotechnologies Inc are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$409,295
Phase II Dollars
$0
Total Awarded
$409,295

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $409,295
Project Title: Single-molecule protein sequencing by iterative isolation and identification of N-terminal amino acids
0 1 NIH $390,584
Project Title: Single-molecule protein sequencing by detection and identification of N-terminal amino acids
0 1 NIH $408,939
Project Title: Single-molecule sequencing of post-translational protein modifications
0 1 NIH $358,981
Project Title: Single-molecule protein sequencing by barcoding of N-terminal amino acids

Key People / Management

  Daniel M Estandian

  Joshua Yang

Company News

There are no news available.